| Literature DB >> 34374750 |
Seth D Merkley1, Samuel M Goodfellow2, Yan Guo1, Zoe E R Wilton1, Janie R Byrum3, Kurt C Schwalm4, Darrell L Dinwiddie4,5, Rama R Gullapalli6, Vojo Deretic3,7, Anthony Jimenez Hernandez1, Steven B Bradfute2, Julie G In1,8, Eliseo F Castillo1,5,7.
Abstract
Intestinal myeloid cells play a critical role in balancing intestinal homeostasis and inflammation. Here, we report that expression of the autophagy-related 5 [Atg5] protein in myeloid cells prevents dysbiosis and excessive intestinal inflammation by limiting IL-12 production. Mice with a selective genetic deletion of Atg5 in myeloid cells [Atg5ΔMye] showed signs of dysbiosis preceding colitis, and exhibited severe intestinal inflammation upon colitis induction that was characterised by increased IFNγ production. The exacerbated colitis was linked to excess IL-12 secretion from Atg5-deficient myeloid cells and gut dysbiosis. Restoration of the intestinal microbiota or genetic deletion of IL-12 in Atg5ΔMye mice attenuated the intestinal inflammation in Atg5ΔMye mice. Additionally, Atg5 functions to limit IL-12 secretion through modulation of late endosome [LE] acidity. Last, the autophagy cargo receptor NBR1, which accumulates in Atg5-deficient cells, played a role by delivering IL-12 to LE. In summary, Atg5 expression in intestinal myeloid cells acts as an anti-inflammatory brake to regulate IL-12, thus preventing dysbiosis and uncontrolled IFNγ-driven intestinal inflammation.Entities:
Keywords: Autophagy; cytokines; inflammation; macrophages; microbiota
Mesh:
Substances:
Year: 2022 PMID: 34374750 PMCID: PMC8864635 DOI: 10.1093/ecco-jcc/jjab144
Source DB: PubMed Journal: J Crohns Colitis ISSN: 1873-9946 Impact factor: 10.020